View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: P&P Group celebrates topping-out ceremony in Germany for the...

Issuer: P&P Group / Key word(s): Real Estate/Expansion P&P Group celebrates topping-out ceremony in Germany for the Sunshine Lofts on the Lagarde Campus in the Bavarian city of Bamberg - Part of one of the most progressive urban neighbourhoods in Europe 26.04.2024 / 09:03 CET/CEST The issuer is solely responsible for the content of this announcement. Bamberg/Fürth, 26. April 2024 – German project developer P&P Group presented the current construction progress of over 300 condominiums at a topping-out ceremony in the new city district on the Lagarde Campus in Bavarian city...

 PRESS RELEASE

EQS-News: P&P Group feiert in Bamberg auf dem Lagarde-Campus das Rich...

Emittent / Herausgeber: P&P Group / Schlagwort(e): Immobilien/Expansion P&P Group feiert in Bamberg auf dem Lagarde-Campus das Richtfest der Sunshine Lofts - Über 300 Eigentumswohnungen in einem der fortschrittlichsten Stadtquartiere Europas 26.04.2024 / 09:03 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bamberg/Fürth, 26. April 2024 – Im Rahmen eines Richtfestes im neuen Stadtviertel auf dem Lagarde-Campus in Bamberg präsentierte der Projektentwickler P&P Group am gestrigen Donnerstag den aktuellen Baufortschritt von über 300 Eig...

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Åsne Holsen
  • Daniel Vårdal Haugland
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Olof Cederholm
Ana Arjona-Martinez ... (+2)
  • Ana Arjona-Martinez
  • Antonio Rodriguez Vicens

Cellnex : Results with no surprises maintain a healthy growth rate

>Organic growth and EBITDA both in line with expectations - Cellnex’s Q1 2024 results were in line with our estimates and with the consensus at the operating level: recurring EBITDA of € 778m vs € 777m from the consensus and € 777m for ODDO BHFe; and EBITDAaL of € 535m vs € 536m from the consensus and € 536m for ODDO BHFe. Organic growth remained strong in the tower business, at a +6.6% increase in PoPs in Q1 2024 (+6.4% in FY 2023), which was still slightly above the...

Nicolas Thorez
  • Nicolas Thorez

Sword Group : Solid Q1 2024 earnings. Outlook confirmed for short and ...

>Q1 2024: further robust organic growth of 16.8% and stable margin of 12% - Sword has reported robust Q1 2024 earnings close to our forecasts. Q1 sales came in at € 75.8m (vs ODDO BHF € 75.4m), up 5.3% y/y in reported terms. After adjustments for the deconsolidation of AAA, this reflected Q1 organic growth of 16.8%, or an acceleration in sequential terms (higher than we were expecting organically) and above the company’s initial budget (+15% org.). By region, this (...

Christophe Chaput
  • Christophe Chaput

Nexity : Un CA T1 en baisse de 14% - 2024 sera un point bas en termes ...

>CA T1 en recul de 14% à 770 M€, niveau cohérent avec nos attentes - Au titre de son T1, le groupe Nexity publie un chiffre d’affaires de 770 M€, -14% y-o-y soit niveau cohérent avec nos estimations (nous retenions 676.1 M€ hors activité d’administration de biens ; sur une base retraitée, notre CA serait de 765.1 M€). Par pôle d’activité, nous retenons : 1/ un CA de la promotion immobilière résidentielle de 489 M€, en baisse de 15% (impact de la baisse des réservation...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

BNP Paribas : Solid Q1 results, full-year guidance confirmed

>Moderate drop in revenues despite a high comparison base in CIB - BNP Paribas reported yesterday stronger-than-expected Q1 2024 results. Revenues fell by 0.4% to € 12.48bn (vs the distributable net income base in Q1 2023), beating forecasts (consensus € 12.2bn and our estimate of € 12.37bn), whereas they fell short of expectations in Q4 2023. Adjusted for the high revenue base in FICC market activities in Q1 2023, underlying growth would have been around 3%. By busin...

Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri

BE Semiconductor Industries : Reprise plus lente que prévu, accélérati...

>Opinion Surperformance réitérée, OC abaissé à 165 € vs 170 € - Le titre BESI était en baisse de 2% hier. Si les commandes T1 et la guidance T2 indiquent clairement une reprise cyclique plus lente que prévu, le groupe a rassuré sur sa dynamique dans l’hybrid bonding et semble en bonne position pour atteindre, voire dépasser les attentes du consensus (107 M€ vs notre estimation à 121 M€ que nous maintenons). Compte tenu d’une reprise plus faible qu’attendu au T2, nous ...

Martijn Den Drijver
  • Martijn Den Drijver

Arcadis : Preview Q1 2024: continued progress in EBITA margin

>Solid organic growth (c. 5%) and EBITA margin progression (60 bps) - Arcadis will publish its Q1 2024 results on April 30 before the close. We forecast organic growth of 4.9% (css at 4.6%, difficult comps given 12.3% in Q1 2023, negative impact working days), driven by robust growth in Resilience (8.5%) and Mobility (9.0%), offset partially by Places (-2.1%, winddown Middle East, focus on margins at DPS, change in market focus China) and some FX headwind. Despite wag...

Jerôme Bodin
  • Jerôme Bodin

WPP : Le T2 devrait être en amélioration séquentielle mais pas d’accél...

>Une valorisation basse mais pas d’amélioration du momentum - WPP a publié son revenu net pour le T1 avec une décroissance organique de 1,6% en ligne avec les indications du groupe et les attentes. Le groupe a confirmé que le T1 serait le point bas et que le T2 devrait afficher une amélioration séquentielle. Nos attentes sont légèrement revues en baisse sous l’effet de l’évolution des changes alors que nos attentes organiques sont inchangées. Nous réitérons notre opi...

Jerôme Bodin
  • Jerôme Bodin

WPP : Q2 should show a sequential improvement but no acceleration in m...

>A low valuation but no improvement in momentum - WPP has reported Q1 revenue with an organic decline of 1.6% in line with the group’s indications and forecasts. The group confirmed that Q1 should mark the low point with a sequential improvement in Q2. We have made a slight downward adjustment to our forecasts due to forex trends, although our organic estimates are unchanged. We reiterate our Neutral recommendation with a new target price of 950p (vs 990p) given the ...

Nicolas Thorez
  • Nicolas Thorez

Assystem : T1 2024 de bonne facture, tiré par le Nucléaire. Guidances ...

>CA T1 de 154.3 M€, en hausse de 5.5% org, légèrement au-dessus des attentes - Assystem a publié hier soir un CA T1 2024 de 154.3 M€ (vs ODDO BHF 150.7 M€), en croissance de 7.2% y-o-y en données publiées, 2% au-dessus de notre prévision initiale. Retraitée des effets périmètre (+1.6pt, contribution plus importante que prévue de L&T et Keops) et Forex (+0.1pt), la croissance organique ressort à 5.5%, légèrement supérieure à ce que nous anticipions (+4.1% org). Cette p...

Jeremy Garnier
  • Jeremy Garnier

STEF : Un début d’année résilient face à un contexte toujours challeng...

>CA T1 de 1139 M€ (vs 1150.1 M€e) en hausse de 5.7% (+0.7% lfl) - STEF a publié hier son CA T1 qui est ressorti à 1 139 M€ en hausse de 5.7% (+0.7% lfl) proche de notre attente de 1150.1 M€e (+6.7%e) reflétant une bonne résilience de l’activité face à un ralentissement de la consommation alimentaire en France.Une dynamique solide soutenue par le déploiement à l’international - La France (~60% du CA T1) enregistre un CA quasiment stable à 576.7 M€ (vs ...

 PRESS RELEASE

Medigene AG reports Financial Results and Business Update for Q1 2024

Medigene AG reports Financial Results and Business Update for Q1 2024 Planegg/Martinsried, April 26, 2024. (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024. The full Quarterly Statement Q1 2024 can be downloaded here: . "During the first quarter of 2024, our focus remained on executing our strategic plan and advancing the development of our unique TCR-T therapies for solid tumors, such as our lead p...

 PRESS RELEASE

Block listing Interim Review

Block listing Interim Review BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Name of applicant:PayPoint PlcName of scheme:a. PayPoint plc Share Incentive Plan b. PayPoint plc Deferred Bonus Plan c. PayPoint plc Long Term Incentive Plan d. PayPoint Restricted Share PlanPeriod of return:From:27/10/2023To:26/04/2024Balance of unallotted securities under scheme(s) from previous return: 398,826 ordinary shares of 1/3p each253,358 ordinary shares of 1/3p each157,903 ordinary shares of 1/3p each273,598 ordinary shares of 1/3p each ...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : BFIT NA, BPOST BB, COFB BB, CRBN NA, MTLS US, PROX BB,...

: BFIT NA, BPOST BB, COFB BB, CRBN NA, MTLS US, PROX BB, UMI BB, XFAB FP, XIOR BB, IMCD NA

 PRESS RELEASE

Fix Price Group PLC: Fix Price announces key operating and financial ...

Fix Price Group PLC (FIXP) Fix Price Group PLC: Fix Price announces key operating and financial results for Q1 2024 26-Apr-2024 / 09:50 MSK   Fix Price announces key operating and financial results for Q1 2024 Keeping focus on unlocking the long-term potential of the business despite market challenges       26 April 2024, Limassol, Cyprus – Fix Price Group PLC (LSE and MOEX: FIXP, AIX: FIXP.Y, “Fix Price”, the “Company” or the “Group”), one of the leading variety value retailers globally and the largest in Russia, today announces its operating and IFRS financ...

Jamila El Bougrini ... (+2)
  • Jamila El Bougrini
  • Thibaut Voglimacci-Stephanopoli

Netcapital Inc: 1 director

A director at Netcapital Inc bought 239,274 shares at 0.132USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch